Speece Thorson Capital Group Inc. lifted its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 51.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 72,778 shares of the medical technology company's stock after acquiring an additional 24,874 shares during the quarter. Teleflex comprises about 2.6% of Speece Thorson Capital Group Inc.'s investment portfolio, making the stock its 22nd biggest holding. Speece Thorson Capital Group Inc. owned 0.16% of Teleflex worth $12,953,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Headlands Technologies LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at $29,000. Avior Wealth Management LLC raised its position in Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after acquiring an additional 125 shares in the last quarter. IFP Advisors Inc lifted its holdings in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after acquiring an additional 217 shares during the last quarter. Exchange Traded Concepts LLC boosted its position in shares of Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after purchasing an additional 94 shares in the last quarter. Finally, R Squared Ltd acquired a new position in shares of Teleflex in the 4th quarter worth approximately $64,000. Institutional investors own 95.62% of the company's stock.
Analysts Set New Price Targets
TFX has been the subject of a number of research reports. Morgan Stanley reduced their target price on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a report on Wednesday, March 5th. Raymond James lowered Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Bank of America downgraded Teleflex from a "neutral" rating to an "underperform" rating and reduced their target price for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Finally, Royal Bank of Canada lowered shares of Teleflex from an "outperform" rating to a "sector perform" rating and reduced their price objective for the company from $220.00 to $155.00 in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $169.63.
Read Our Latest Stock Report on TFX
Teleflex Stock Up 1.8 %
Shares of TFX stock traded up $2.42 during trading on Thursday, hitting $135.44. 691,766 shares of the company were exchanged, compared to its average volume of 627,694. The firm has a market capitalization of $6.28 billion, a price-to-earnings ratio of 26.93, a P/E/G ratio of 1.73 and a beta of 1.19. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The business's 50-day simple moving average is $141.49 and its 200 day simple moving average is $175.69. Teleflex Incorporated has a twelve month low of $124.66 and a twelve month high of $249.91.
Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. As a group, analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.00%. Teleflex's dividend payout ratio (DPR) is presently 95.77%.
About Teleflex
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also

Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.